Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients

Clinical trial NCT05221775 · UNKNOWN

Trial details

NCT number: NCT05221775
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

First-line Treatment Advanced Gastric Carcinoma

Start date: 2021-11-01
Primary completion: 2023-03-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.